Weimaining Capsules

　＃　Weimaining Capsules are produced by Huayi Pharmaceutical Co. Ltd., an indirect subsidiary of China National Group Corp of Traditional & Herbal Medicine and Shenzhen Kangzhe Pharmacutical Co., Ltd. is the sole distributor of the product in P. R. China.

　＃　It may be used in lung cancer patients who are not suitable for radiotherapy and chemotherapy cancer treatments.
　＃　Weimaining Capsules have been included in the National Basic Insurance Drug List in PRC, under Category B.

　＃　From 2000 to 2005, there were 120,000 reported new cases of lung cancer, to a total of 500,000 patients in 2005. Being the exclusive distribution agent of Weimaining Capsules in China, starting from 2007, CMS believes that there will be great market potential for Weimaining Capsules, and will market them as strictly prescription medicine, at acceptable end user price.
©2006 CMS，Shenzhen Kangzhe Pharmaceutical Co., Ltd. All Rights Reserved.